Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DMT Entities
Recent news which mentions DMT Entities
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
July 28, 2023
Tickers
ATAI
CMPS
DMTTF
DRUG
Tags
Financing
GHRS
Small Cap
From
Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
June 29, 2023
Tickers
DMTTF
Tags
DMT Entities
News
Psychedelics
From
Benzinga
Small Pharma's IP Portfolio Grows With Numerous Approved Patent Applications Around The World
May 26, 2023
Tickers
DMTTF
Tags
DMT Entities
Psychedelics
Cannabis
From
Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
May 24, 2023
Tickers
CYBN
Tags
Psychedelics
CYBN
DMT Entities
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
Market News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial
April 04, 2023
Tickers
DMTTF
Tags
Cannabis
Markets
Market News
From
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
April 04, 2023
Tickers
AGNPF
Tags
Penny Stocks
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Small Pharma Inc: Positive Clinical Data For Major Depressive Disorder, Upcoming Virtual Roundtable
March 08, 2023
Tickers
DMTTF
Tags
DMT Entities
Psychedelics
major depressive disorder
From
Benzinga
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
February 22, 2023
Tickers
LMLLF
PHRRF
Tags
Markets
LMLLF
Ocular Diseases
From
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
February 21, 2023
Tickers
AGNPF
TBI
Tags
Management
General
Legal
From
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
Tags
DMT Entities
Health Care
Psychedelics
From
Benzinga
Short-Acting Psychedelics: DMT-Based Drug Therapy Gets Tested In New Clinical Trial
February 15, 2023
Tickers
DMTTF
Tags
Global
Penny Stocks
Benzinga
From
Benzinga
Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment
February 14, 2023
Tickers
CYBN
Tags
Market News
Cannabis
Financing
From
Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
Tags
Psychedelics
DMT Entities
Benzinga
From
Benzinga
Small Pharma, Inc's Psychedelics For Major Depression Trial Results And Q1 Earnings
January 25, 2023
Tickers
DMTTF
Tags
Markets
DMTTF
Earnings
From
Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
January 16, 2023
Tickers
CYBN
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga
Encountering DMT Entities: Are They Real?
June 23, 2022
Tickers
DMT
Tags
DMT Entities
Psychedelics
Cannabis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.